Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Multiple Myeloma

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Innocenti, A; Nencetti, S; Nuti, E; Orlandini, E; Rossello, A; Scozzafava, A; Supuran, CT1

Other Studies

1 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Multiple Myeloma

ArticleYear
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
    Bioorganic & medicinal chemistry, 2007, Mar-15, Volume: 15, Issue:6

    Topics: Animals; Carbonic Anhydrase I; Carbonic Anhydrase II; Cytosol; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isoenzymes; Matrix Metalloproteinase Inhibitors; Mice; Molecular Structure; Multiple Myeloma; Structure-Activity Relationship; Sulfonic Acids; Tumor Cells, Cultured

2007